Letrozole, an aromatase inhibitor that blocks estrogen synthesis by inhibiting the final step of
the estrogen biosynthetic pathway, has been used in the applications of a wide range of …

It has been proven that the use of high gonadotropin dose does not necessarily improve the
final outcome of IVF. Mild ovarian stimulation is based on the principle of optimal utilization …

The infertile patients with aging ovaries—also sometimes referred to as impending
premature ovarian insufficiency (POI), impending premature ovarian failure (POF), or poor …

Diminished fertility and poor ovarian response pose a conundrum to the experts in the field
of reproductive medicine. There is limited knowledge about the risk factors of diminished …

Letrozole reduces serum oestradiol by inhibiting the aromatase enzyme and has growing
clinical indications in fertility. The available evidence of letrozole's role in ovarian stimulation …

There has been increasing interest in combining the oral agents clomiphene citrate (CC)
and letrozole with gonadotropins in IVF: for poor responders to reduce the amount of …

High DNA fragmentation index (DFI) may be associated with poor outcome after IVF. Our
aim was to determine whether DFI impacts blastocyst quality or clinical outcome. This …

Infertility in developing countries is a distinct and complex problem that disproportionately
affects women. Though not a physically restraining disease, it causes a huge social burden …

Background For the last year we have been treating normal responders with gonadotropins
and letrozole during the whole stimulation in order to improve response to FSH by …

Female infertility is defined as the failure to conceive after a year of frequent, unprotected
sexual activity. Infertility affects 8-10% of females worldwide. There are many causes of …